Diagnosis | Surgery | Chemotherapy | Radiotherapy | Other inpatient care | Continuing care | Total cost | |
---|---|---|---|---|---|---|---|
NSCLC (sum, %) | |||||||
Stage I | 28,573 | 306,114 | 27,280 | 12,755 | 102,652 | 42,153 | 519,526 |
5.5% | 58.9% | 5.3% | 2.5% | 19.8% | 8.1% | 100.0% | |
Stage II | 16,106 | 81,416 | 27,624 | 6,538 | 32,288 | 13,348 | 177,320 |
9.1% | 45.9% | 15.6% | 3.7% | 18.2% | 7.5% | 100.0% | |
Stage III | 119,463 | 71,598 | 98,958 | 25,969 | 128,901 | 30,957 | 475,846 |
25.1% | 15.0% | 20.8% | 5.5% | 27.1% | 6.5% | 100.0% | |
Stage IV | 287,012 | 22,863 | 488,195 | 23,205 | 227,928 | 18,930 | 1,068,133 |
26.9% | 2.1% | 45.7% | 2.2% | 21.3% | 1.8% | 100.0% | |
Unknown | 71,792 | 98,615 | 111,030 | 900 | 15,828 | 9,670 | 307,835 |
23.3% | 32.0% | 36.1% | 0.3% | 5.1% | 3.1% | 100.0% | |
Total (N = 172) | 522,946 | 580,605 | 753,087 | 69,367 | 507,597 | 115,058 | 2,548,661 |
20.5% | 22.8% | 29.5% | 2.7% | 19.9% | 4.5% | 100.0% | |
SCLC (sum, %) | |||||||
Limited disease | 11,822 | - | 33,959 | 11,699 | 42,933 | 7,516 | 107,929 |
11.0% | 31.5% | 10.8% | 39.8% | 7.0% | 100.0% | ||
Extensive disease | 45,011 | - | 83,077 | 10,928 | 48,729 | 11,962 | 199,707 |
22.5% | 41.6% | 5.5% | 24.4% | 6.0% | 100.0% | ||
Unknown | 14,584 | - | 67 | - | 1,266 | 526 | 16,444 |
88.7% | 0.4% | 7.7% | 3.2% | 100.0% | |||
Total (N = 26) | 71,417 | - | 117,103 | 22,627 | 92,928 | 20,005 | 324,079 |
22.0% | 36.1% | 7.0% | 28.7% | 6.2% | 100.0% | ||
NCC (sum, %) | |||||||
Stage I | 2,195 | 16,844 | - | - | 83,428 | 701 | 103,168 |
2.1% | 16.3% | 80.9% | 0.7% | 100.0% | |||
Stage II | - | - | - | - | - | - | - |
Stage III | 8,122 | - | 7,400 | - | 5,875 | 1,880 | 23,277 |
34.9% | 31.8% | 25.2% | 8.1% | 100.0% | |||
Stage IV | 58,543 | 7,835 | 81,106 | 4,747 | 32,462 | 2,973 | 187,665 |
31.2% | 4.2% | 43.2% | 2.5% | 17.3% | 1.6% | 100.0% | |
Unknown | 62,873 | 10,660 | 2,335 | - | 20,794 | 1,698 | 98,360 |
63.9% | 10.8% | 2.4% | 21.1% | 1.7% | 100.0% | ||
Total (N = 34) | 131,734 | 35,339 | 90,841 | 4,747 | 142,559 | 7,252 | 412,472 |
31.9% | 8.6% | 22.0% | 1.2% | 34.6% | 1.8% | 100.0% |